ArticleFrontiers in immunology2022

Preclinical Assessment of IgY Antibodies Against Recombinant SARS-CoV-2 RBD Protein for Prophylaxis and Post-Infection Treatment of COVID-19.

Andres Agurto-Arteaga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.